Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1852 1
1964 1
1981 4
1982 5
1983 1
1984 5
1985 2
1986 3
1987 3
1988 2
1989 4
1990 8
1991 1
1992 2
1993 7
1994 4
1995 2
1996 5
1997 6
1998 5
1999 4
2000 6
2001 7
2002 4
2003 1
2004 2
2005 6
2006 2
2007 7
2008 5
2009 9
2010 15
2011 14
2012 9
2013 12
2014 12
2015 12
2016 15
2017 11
2018 5
2019 3
2020 7
2021 4
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia.
Locatelli F, Thompson AA, Kwiatkowski JL, Porter JB, Thrasher AJ, Hongeng S, Sauer MG, Thuret I, Lal A, Algeri M, Schneiderman J, Olson TS, Carpenter B, Amrolia PJ, Anurathapan U, Schambach A, Chabannon C, Schmidt M, Labik I, Elliot H, Guo R, Asmal M, Colvin RA, Walters MC. Locatelli F, et al. Among authors: porter jb. N Engl J Med. 2022 Feb 3;386(5):415-427. doi: 10.1056/NEJMoa2113206. Epub 2021 Dec 11. N Engl J Med. 2022. PMID: 34891223 Clinical Trial.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Among authors: porter jb. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Iron Through the Prism of Haematology.
Porter JB. Porter JB. Br J Haematol. 2020 Nov;191(4):587-592. doi: 10.1111/bjh.17164. Br J Haematol. 2020. PMID: 33190267 Free article. Review.
Deferoxamine pharmacokinetics.
Porter JB. Porter JB. Semin Hematol. 2001 Jan;38(1 Suppl 1):63-8. doi: 10.1016/s0037-1963(01)90061-7. Semin Hematol. 2001. PMID: 11206963 Review.
Iron chelator design.
Hider RC, Epemolu O, Singh S, Porter JB. Hider RC, et al. Among authors: porter jb. Adv Exp Med Biol. 1994;356:343-9. doi: 10.1007/978-1-4615-2554-7_36. Adv Exp Med Biol. 1994. PMID: 7887240 Review. No abstract available.
Red blood cell-derived microparticles: An overview.
Westerman M, Porter JB. Westerman M, et al. Among authors: porter jb. Blood Cells Mol Dis. 2016 Jul;59:134-9. doi: 10.1016/j.bcmd.2016.04.003. Epub 2016 Apr 13. Blood Cells Mol Dis. 2016. PMID: 27282583 Review.
The pathophysiology of transfusional iron overload.
Porter JB, Garbowski M. Porter JB, et al. Hematol Oncol Clin North Am. 2014 Aug;28(4):683-701, vi. doi: 10.1016/j.hoc.2014.04.003. Hematol Oncol Clin North Am. 2014. PMID: 25064708 Review.
Deferasirox: an update.
Porter JB. Porter JB. Hemoglobin. 2009;33 Suppl 1:S70-5. doi: 10.3109/03630260903347146. Hemoglobin. 2009. PMID: 20001635 Review.
228 results